Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study

NCT00309712 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Type II Diabetes Mellitus
Mixed Dyslipidemia

Interventions

DRUG: fenofibrate 160 mg and placebo
DRUG: simvastatin 20 mg and placebo
DRUG: fenofibrate 160 mg and simvastatin 20 mg

Sponsor

Intermountain Health Care, Inc.

Collaborators

[object Object]
[object Object]